Provider review
CLYR Health review
Bills on eight-week cycles while quoting the price per month.
Eight weeks recurs six and a half times a year, and the page does not say which charge lands when.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
CLYR Health
$199 on eight-week cycles after a $149 first month
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things here are done well and one is genuinely confusing. Done well: the introductory rate and the standing rate are both on the page, so the step is visible before you start rather than at the second charge, and the inclusion list is specific enough to be useful — consultation, prescription, ongoing dose adjustments and priority shipping, all named rather than gestured at. The confusing part is the cadence. Billing runs on eight-week cycles and the figure is described per month, which are not the same unit, and nothing says whether the charge lands every eight weeks or monthly within a cycle. Eight weeks comes round six and a half times a year; twelve months come round twelve. Those produce materially different annual costs from the same number, and you cannot tell from the page which one you are being quoted. A second pricing tier exists at a considerably higher figure with no explanation of what puts somebody in it. The pharmacy class is referenced repeatedly; no milligram appears.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the first-month and standing rates both stated before starting
- You want ongoing dose adjustments named as part of what you are paying for
- You will ask how often the charge actually lands
Look elsewhere if
- You are budgeting annually — the cycle is eight weeks, not a month
- You want to know what puts you into the higher tier
- You want a dose behind the number
What it actually costs
Price as published
AN EIGHT-WEEK CYCLE, WHICH IS AN UNUSUAL DENOMINATOR EVEN HERE: "$149 first month. Then $199/mo on 8-week cycles · Tier 2 from $399" · eight weeks recurs 6.52 times a year, so a figure described per month on an eight-week cycle is doing something a reader cannot check without knowing whether $199 is charged every eight weeks or every month within them · ★ the first-month rate and the standing rate are both printed, which is the right disclosure and rarer than it should be · the inclusion list is specific — provider consultation and prescription, ongoing dosing adjustments, free priority shipping · a second tier is priced "from $399" with no explanation of what moves a reader into it · the 503A class is referenced six times and cancel-anytime three times · no milligram is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Billing runs on EIGHT-WEEK cycles while the figure is quoted per month — a denominator that is neither a month nor a quarter, recurring six and a half times a year. The page does not say which charge lands when, so the annual cost cannot be worked out. ★ The introductory and standing rates are both published and the inclusion list is specific, which is more than most manage. A second tier exists with no stated entry criterion.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Publishes the first-month rate and the standing rate together.
- Names what the fee covers, including ongoing dose adjustments.
- References the pharmacy class repeatedly and states cancellation terms.
Pharmacy, labs and oversight
CLYR Health dispenses through a 503A referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What CLYR Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things here are done well and one is genuinely confusing. Done well: the introductory rate and the standing rate are both on the page, so the step is visible before starting rather than at the second charge, and the inclusion list is specific enough to be useful — consultation, prescription, ongoing dose adjustments and shipping, all named. The confusing part is the cadence. Billing runs on eight-week cycles and the figure is described per month, which are not the same unit, and the page does not say whether the charge lands every eight weeks or monthly within a cycle. Eight weeks recurs six and a half times a year; twelve months recur twelve. Those produce materially different annual costs from the same number, and a reader cannot tell which they are being quoted. A second pricing tier exists at a higher figure with no explanation of what puts someone in it. The pharmacy class is referenced repeatedly; no milligram appears.
The honest cons
Billing runs on eight-week cycles while the figure is quoted per month.
- A second, higher tier exists with no stated criterion for entering it.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
CLYR Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#348 of 373
Ordered with the companies that pay us first, and CLYR Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.